Featured Research

from universities, journals, and other organizations

Researcher Successfully Vaccinates Some Patients Against Lung Cancer

Date:
February 20, 2004
Source:
Baylor University Medical Center
Summary:
John Nemunaitis, M.D., oncologist and researcher at the Mary Crowley Medical Research Center (MCMRC) at Baylor University Medical Center at Dallas, has developed a vaccine that suppresses lung cancer in some patients.

Dallas, TX (Feb. 18, 2004) -- John Nemunaitis, M.D., oncologist and researcher at the Mary Crowley Medical Research Center (MCMRC) at Baylor University Medical Center at Dallas, has developed a vaccine that suppresses lung cancer in some patients. Results of the clinical trial are published in today’s Journal of the National Cancer Institute in a paper titled “Phase I/II Study of GVAX® in Non-Small Cell Lung Cancer (NSCLC).”

Related Articles


NSCLC is the leading cause of cancer death for men and women in the United States. More than 150,000 people die from the disease each year.

In Dr. Nemunaitis’s research trial 43 patients with early and advanced stage NSCLC were injected with the vaccine, called GVAX®. Vaccines were administered every two weeks for a total of three to six vaccinations.

“While it’s premature to call this a cure, we found that in a small number of people who were sensitive to this approach, the cancer hasn’t come back. And, for a number of patients, it has been more than three years since they received the vaccine,” said John Nemunaitis, M.D., principal investigator of the study at Baylor University Medical Center at Dallas.

Researchers developed the vaccine using cells obtained from each patient’s tumor. A gene, called GM-CSF, is placed into the cancer cells to change the surface of the cells so the body can identify the cells as cancerous. Once the vaccine is injected, the body’s immune cells come to the injection site and start to work with lymphocytes, immune cells that help rid the body of an infection.

“We’re trying to turn on the lymphocytes so they can identify the cancer cells and clear it, just like the body clears the cold or flu virus or an infection,” Dr. Nemunaitis said.

Three patients with advanced stage lung cancer experienced complete remission of their disease lasting six months, 18 months and ongoing at 22 months. For two of these patients, prior treatment with chemotherapy had failed. One patient experienced a 30-percent decrease in the size of a lung nodule, and for seven patients, their disease remained stable and did not progress for a period ranging from almost five months to more than 28 months.

“These results are very promising for patients with non-small cell lung cancer, which is frequently resistant to chemotherapy,” Dr. Nemunaitis said. “We believe this study is the first time immune therapy has been the sole treatment associated with complete and durable regression of metastatic NSCLC lesions, particularly those lasting more than one year, as observed in two patients in our study.”

While chemotherapy is an option for patients with advanced disease, results show a 15 to 21 percent response rate, median survival of 7.4 to 8.2 months and one year overall survival of 31 to 36 percent. Early-stage patients undergoing complete surgical resection have a greater than 75 percent chance of surviving one year, but survival is reduced to 35 to 50 percent at five years largely as a result of disease that recurs.

Dr. Nemunaitis conducted his research through the Baylor Research Institute and the Mary Crowley Medical Research Center at Baylor. The center is one of the largest patient treatment sites for gene therapy in the country and is supported by gifts from Home Interiors & Gifts, Don and Linda Carter, Ruth Shanahan, Mr. H.T. Ardinger, Jr., and the E.K. Boon Family. For more information about cancer research studies at the Mary Crowley Medical Research Center at Baylor University Medical Center at Dallas, visit www.MCMRC.com.

Baylor University Medical Center at Dallas is a leading patient care and research center for the Southwest. With more than 1,000 beds and 900 physicians on staff, Baylor is recognized by U.S. News & World Report among America’s best hospitals in a range of medical specialties. Currently at Baylor, more than 500 research protocols are under way.


Story Source:

The above story is based on materials provided by Baylor University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Baylor University Medical Center. "Researcher Successfully Vaccinates Some Patients Against Lung Cancer." ScienceDaily. ScienceDaily, 20 February 2004. <www.sciencedaily.com/releases/2004/02/040220075420.htm>.
Baylor University Medical Center. (2004, February 20). Researcher Successfully Vaccinates Some Patients Against Lung Cancer. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2004/02/040220075420.htm
Baylor University Medical Center. "Researcher Successfully Vaccinates Some Patients Against Lung Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/02/040220075420.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) — The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) — Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) — Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Raw: Paralyzed Marine Walks With Robotic Braces

Raw: Paralyzed Marine Walks With Robotic Braces

AP (Nov. 21, 2014) — Marine Corps officials say a special operations officer left paralyzed by a sniper's bullet in Afghanistan walked using robotic leg braces in a ceremony to award him a Bronze Star. (Nov. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins